Ghulam A. Shabir
Research Subjects
Ghulam A. Shabir has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Shafique A. Arain
Department of Pure and Applied Chemistry , University of Strathclyde , Glasgow , U.K.
4 shared publicationsAbdul Hamid
Chief Education Planning and Development Division , Islamabad , Pakistan
2 shared publicationsNigel J. Forrow
Abbott Laboratories, R&D , Range Road, Witney, Oxon OX29 0YL, U.K.
1 shared publicationTony K. Bradshaw
School of Life Sciences, Oxford Brookes University , Oxford, U.K.
1 shared publicationW. John Lough
Sunderland Pharmacy School, University of Sunderland , Sunderland, U.K.
1 shared publication
Latest Publications
- Open Access
- 1 August 2008
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 46 (7) , 643-8
Development and validation of a liquid chromatography-mass spectrometry method for the determination of 4,5-diazafluoren-9-one.
A new liquid chromatography—mass spectrometry (LC—MS) method is developed and validated for the identification and determination of novel 4,5-diazafluoren-9-one compound. The method employs a Waters XTerra RP-18 column (150 mm × 4.6 mm, i.d. 5 μm) with a mobile phase comprised of a (50:50, v/v) mixture of deionized water containing 0.2% acetic acid (solvent A) and methanol (solvent B) at a flow rate of 1 mL/min, at 35°C. The detection is performed with photodiode-array (PDA) set at 210–400 nm and single quadropole mass spectrometer with electrospray ionization (ESI) positive ion mode. The chromatographic separation is achieved in less than 3 min. The linearity is established over the concentration range of 0.1–0.5 mg/mL (r2 = 1.000). The mean RSD values for intra- and inter-day precision studies are < 2%. The recovery of 4,5-diazafluoren-9-one ranged between 99.84 and 99.97%. The limits of detection and quantitation are determined to be 0.58 and 0.1 mg/mL, respectively.
- 1 August 2008
- Published by Oxford University Press (OUP) in Journal of Chromatographic Science
- Vol. 46 (7) , 643-8
Open AccessDevelopment and validation of a liquid chromatography-mass spectrometry method for the determination of 4,5-diazafluoren-9-one.
A new liquid chromatography—mass spectrometry (LC—MS) method is developed and validated for the identification and determination of novel 4,5-diazafluoren-9-one compound. The method employs a Waters XTerra RP-18 column (150 mm × 4.6 mm, i.d. 5 μm) with a mobile phase comprised of a (50:50, v/v) mixture of deionized water containing 0.2% acetic acid (solvent A) and methanol (solvent B) at a flow rate of 1 mL/min, at 35°C. The detection is performed with photodiode-array (PDA) set at 210–400 nm and single quadropole mass spectrometer with electrospray ionization (ESI) positive ion mode. The chromatographic separation is achieved in less than 3 min. The linearity is established over the concentration range of 0.1–0.5 mg/mL (r2 = 1.000). The mean RSD values for intra- and inter-day precision studies are < 2%. The recovery of 4,5-diazafluoren-9-one ranged between 99.84 and 99.97%. The limits of detection and quantitation are determined to be 0.58 and 0.1 mg/mL, respectively.
- 23 January 2008
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (4) , 497-508
Development and Validation of an HPLC Method for the Determination of 2‐(4‐Isobutylphenyl) Propionic Acid and 4‐Isobutylacetophenone in a Gel Formulation
A simple isocratic reversed‐phase high performance liquid chromatographic (HPLC) method was developed for the determination of 2‐(4‐isobutylphenyl) propionic acid and its major impurity 4‐isobutylacetophenone in a gel formulation. The chromatographic separation was achieved with sodium phosphate buffer (pH 3.0) and methanol (40∶60, v/v) as mobile phase, a ChromSpher C18 column (100 mm×3 mm and 5 µm), and UV detection at 220 nm. The analysis time was less than 10 min. The method was validated with respect to linearity, range, precision, accuracy, specificity, and robustness. The calibration curves showed good linearity over the concentration range of 0.10–80 µg/mL. The correlation coefficients were ≥0.9997 in each case. The RSD values for intra‐ and inter‐day precision studies were less than 0.50%. The procedure described here is simple, selective, and is suitable for routine quality control analysis.
- 23 January 2008
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (4) , 497-508
Development and Validation of an HPLC Method for the Determination of 2‐(4‐Isobutylphenyl) Propionic Acid and 4‐Isobutylacetophenone in a Gel Formulation
A simple isocratic reversed‐phase high performance liquid chromatographic (HPLC) method was developed for the determination of 2‐(4‐isobutylphenyl) propionic acid and its major impurity 4‐isobutylacetophenone in a gel formulation. The chromatographic separation was achieved with sodium phosphate buffer (pH 3.0) and methanol (40∶60, v/v) as mobile phase, a ChromSpher C18 column (100 mm×3 mm and 5 µm), and UV detection at 220 nm. The analysis time was less than 10 min. The method was validated with respect to linearity, range, precision, accuracy, specificity, and robustness. The calibration curves showed good linearity over the concentration range of 0.10–80 µg/mL. The correlation coefficients were ≥0.9997 in each case. The RSD values for intra‐ and inter‐day precision studies were less than 0.50%. The procedure described here is simple, selective, and is suitable for routine quality control analysis.
- 20 December 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (3) , 428-442
Development and Validation of an LC Assay for Benzo[f]quinoline‐5,6‐dione and Identification of its Impurities by LC‐MS
A new analytical method based on reversed‐phase high performanc liquid chromatography (HPLC) was developed and validated for the assay of benzo[f]quinoline‐5,6‐dione and the determination of its synthetic impurities by employing the method in liquid chromatography‐mass spectrometry (LC‐MS) with electrospray ionization (ESI) and photodiode array (PDA) UV detection. Separation was performed on a Waters Xterra C18 (150 mm×4.6 mm, 5 µm) column. UV detection was performed at 262 nm. The results showed that benzo[f]quinoline‐5,6‐dione is eluted as a spectrally pure peak resolved from its impurities. 1H‐indeno[2,1‐b]pyridine‐2,9‐dion and benzo[f]quinoline are identified as the main impurities. The proposed method was extensively validated and satisfactory results were obtained in terms of linearity (r 2 =0.9997) and precision (RSD<0.61%) in all cases. The limits of detection and quantification were 2 µg/mL and 20 µg/mL, with a 0.88% RSD, respectively.
- 20 December 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (3) , 428-442
Development and Validation of an LC Assay for Benzo[f]quinoline‐5,6‐dione and Identification of its Impurities by LC‐MS
A new analytical method based on reversed‐phase high performanc liquid chromatography (HPLC) was developed and validated for the assay of benzo[f]quinoline‐5,6‐dione and the determination of its synthetic impurities by employing the method in liquid chromatography‐mass spectrometry (LC‐MS) with electrospray ionization (ESI) and photodiode array (PDA) UV detection. Separation was performed on a Waters Xterra C18 (150 mm×4.6 mm, 5 µm) column. UV detection was performed at 262 nm. The results showed that benzo[f]quinoline‐5,6‐dione is eluted as a spectrally pure peak resolved from its impurities. 1H‐indeno[2,1‐b]pyridine‐2,9‐dion and benzo[f]quinoline are identified as the main impurities. The proposed method was extensively validated and satisfactory results were obtained in terms of linearity (r 2 =0.9997) and precision (RSD<0.61%) in all cases. The limits of detection and quantification were 2 µg/mL and 20 µg/mL, with a 0.88% RSD, respectively.
- 1 September 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (19) , 2851-2862
Development and Validation of an HPLC Method for the Determination of 2‐(4‐Isobutylphenyl) Propionic Acid and 4‐Isobutylacetophenone in a Gel Formulation
A simple isocratic reversed‐phase high performance liquid chromatographic (HPLC) method was developed for the determination of 2‐(4‐isobutylphenyl) propionic acid and its major impurity 4‐isobutylacetophenone in a gel formulation. The chromatographic separation was achieved with sodium phosphate buffer (pH 3.0) and methanol (40:60, v/v) as mobile phase, a ChromSpher C18 column (100 mm×3 mm and 5 µm), and UV detection at 220 nm. The analysis time was less than 10 min. The method was validated with respect to linearity, range, precision, accuracy, specificity, and robustness. The calibration curves showed good linearity over the concentration range of 0.10–80 µg/mL. The correlation coefficients were ≥0.9997 in each case. The RSD values for intra‐ and inter‐day precision studies were less than 0.50%. The procedure described here is simple, selective, and is suitable for routine quality control analysis.
- 1 September 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (19) , 2851-2862
Development and Validation of an HPLC Method for the Determination of 2‐(4‐Isobutylphenyl) Propionic Acid and 4‐Isobutylacetophenone in a Gel Formulation
A simple isocratic reversed‐phase high performance liquid chromatographic (HPLC) method was developed for the determination of 2‐(4‐isobutylphenyl) propionic acid and its major impurity 4‐isobutylacetophenone in a gel formulation. The chromatographic separation was achieved with sodium phosphate buffer (pH 3.0) and methanol (40:60, v/v) as mobile phase, a ChromSpher C18 column (100 mm×3 mm and 5 µm), and UV detection at 220 nm. The analysis time was less than 10 min. The method was validated with respect to linearity, range, precision, accuracy, specificity, and robustness. The calibration curves showed good linearity over the concentration range of 0.10–80 µg/mL. The correlation coefficients were ≥0.9997 in each case. The RSD values for intra‐ and inter‐day precision studies were less than 0.50%. The procedure described here is simple, selective, and is suitable for routine quality control analysis.
- 18 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (13) , 1951-1962
Method Development and Validation of Preservatives Determination (Benzyl Alcohol, Ethylene Glycol Monophenyl Ether, Methyl Hydroxybenzoate, Ethyl Hydroxybenzoate, Propyl Hydroxybenzoate, and Butyl Hydroxybenzoate) using HPLC
The purpose of the research described herein was to develop a new high performance liquid chromatography (HPLC) method for the assay of benzyl alcohol, ethylene glycol monophenyl ether, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, and butyl hydroxybenzoate preservatives. The use of a reversed‐phase C18 column (250 mm×4.0 mm and 5 µm) using a gradient elution system enabled six compounds to be separated simultaneously in a single chromatographic run in less than 12 minutes. The method was successfully validated following ICH guidelines, and it has been demonstrated to be reliable for the assay of benzyl alcohol, ethylene glycol monophenyl ether, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, and butyl hydroxybenzoate preservatives used in the manufacturing of drug products.
- 18 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (13) , 1951-1962
Method Development and Validation of Preservatives Determination (Benzyl Alcohol, Ethylene Glycol Monophenyl Ether, Methyl Hydroxybenzoate, Ethyl Hydroxybenzoate, Propyl Hydroxybenzoate, and Butyl Hydroxybenzoate) using HPLC
The purpose of the research described herein was to develop a new high performance liquid chromatography (HPLC) method for the assay of benzyl alcohol, ethylene glycol monophenyl ether, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, and butyl hydroxybenzoate preservatives. The use of a reversed‐phase C18 column (250 mm×4.0 mm and 5 µm) using a gradient elution system enabled six compounds to be separated simultaneously in a single chromatographic run in less than 12 minutes. The method was successfully validated following ICH guidelines, and it has been demonstrated to be reliable for the assay of benzyl alcohol, ethylene glycol monophenyl ether, methyl hydroxybenzoate, ethyl hydroxybenzoate, propyl hydroxybenzoate, and butyl hydroxybenzoate preservatives used in the manufacturing of drug products.
- 18 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (13) , 1923-1932
Method Development and Validation of 9α‐Fluoro‐16β‐Methyl‐Prednisolone‐17‐Valerate by HPLC
In this study, the development and validation of an analytical method for the assay of 9α‐fluoro‐16β‐methyl‐prednisolone‐17‐valerate (FMPV) using reversed‐phase high performance liquid chromatography (HPLC) is reported. The chromatographic separation is achieved with methanol‐water (63:37, v/v) as mobile phase, a C18 column, and UV detection at 240 nm. The method was critically validated to demonstrate its selectivity, linearity, precision, accuracy, specificity, limit of detection and quantitation. The calibration curve showed good linearity (r 2=0.9999) over the concentration range 20 to 150 µg/mL. The mean percent relative standard deviation values for precision studies were less than 0.37%. Mean recoveries were 99.73–100.02%. The limit of detection was 3.0 µg/mL and limit of quantitation was 20.0 µg/mL. This method represents a useful protocol for routine testing of 9α‐fluoro‐16β‐methyl‐prednisolone‐17‐valerate drug substance.
- 18 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (13) , 1923-1932
Method Development and Validation of 9α‐Fluoro‐16β‐Methyl‐Prednisolone‐17‐Valerate by HPLC
In this study, the development and validation of an analytical method for the assay of 9α‐fluoro‐16β‐methyl‐prednisolone‐17‐valerate (FMPV) using reversed‐phase high performance liquid chromatography (HPLC) is reported. The chromatographic separation is achieved with methanol‐water (63:37, v/v) as mobile phase, a C18 column, and UV detection at 240 nm. The method was critically validated to demonstrate its selectivity, linearity, precision, accuracy, specificity, limit of detection and quantitation. The calibration curve showed good linearity (r 2=0.9999) over the concentration range 20 to 150 µg/mL. The mean percent relative standard deviation values for precision studies were less than 0.37%. Mean recoveries were 99.73–100.02%. The limit of detection was 3.0 µg/mL and limit of quantitation was 20.0 µg/mL. This method represents a useful protocol for routine testing of 9α‐fluoro‐16β‐methyl‐prednisolone‐17‐valerate drug substance.
- 7 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (12) , 1763-1775
Determination of a Novel Assay for Pregn‐4‐ene‐3,20‐dione in a Gel Formulation Using High‐Performance Liquid Chromatography
A reversed‐phase high performance liquid chromatographic (RP‐HPLC) method was developed and validated for the determination of pregn‐4‐ene‐3,20‐dione in a gel formulation. The chromatographic separation was achieved with methanol‐water (75:25, v/v) as mobile phase, a C18 column (250×4.6 mm; 10 µm), and UV detection at 254 nm. The calibration curve was linear (r 2=0.9999) from 25–150% of the analytical concentration of 40 µg/mL. The mean percent relative standard deviation values for intra‐ and interday precision studies were less than 1%. The recovery ranges were 98.61–100.76% from a gel formulation. The limits of detection and quantitation were determined to be 10 and 20 ηg/mL, respectively. The method was specific and successfully routinely used in quality control for analysis of pregn‐4‐ene‐3,20‐dione bulk gel samples and final product release.
- 7 May 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (12) , 1763-1775
Determination of a Novel Assay for Pregn‐4‐ene‐3,20‐dione in a Gel Formulation Using High‐Performance Liquid Chromatography
A reversed‐phase high performance liquid chromatographic (RP‐HPLC) method was developed and validated for the determination of pregn‐4‐ene‐3,20‐dione in a gel formulation. The chromatographic separation was achieved with methanol‐water (75:25, v/v) as mobile phase, a C18 column (250×4.6 mm; 10 µm), and UV detection at 254 nm. The calibration curve was linear (r 2=0.9999) from 25–150% of the analytical concentration of 40 µg/mL. The mean percent relative standard deviation values for intra‐ and interday precision studies were less than 1%. The recovery ranges were 98.61–100.76% from a gel formulation. The limits of detection and quantitation were determined to be 10 and 20 ηg/mL, respectively. The method was specific and successfully routinely used in quality control for analysis of pregn‐4‐ene‐3,20‐dione bulk gel samples and final product release.
- 1 February 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (3) , 311-333
Evaluation and Application of Best Practice in Analytical Method Validation
Method validation is an important part of analytical chemistry to confirm that the method employed for a specific test is suitable for its intended use. As such, it is an essential requirement for any package of information submitted to regulatory agencies in support of new product marketing or clinical trial applications. Currently, there is no single source or final guideline on analytical method validation that helps analysts to perform validation in a systematic manner. Therefore, industry depends on the analyst's knowledge and experience to develop simple and efficient methods of analysis. The intention of this paper is to review regulatory requirements and role of the pharmacopeias and to study how analytical method development and validation are typically carried out at present, and to formulate this into a simple step by step approach. Such a template was not only used as the foundation of this research programme, but could also serve as a simple systematic guide for other practitioners and those new to the field. Furthermore, it was recognized that this protocol should satisfy the requirements of the most strategically important regulatory bodies.
- 1 February 2007
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 30 (3) , 311-333
Evaluation and Application of Best Practice in Analytical Method Validation
Method validation is an important part of analytical chemistry to confirm that the method employed for a specific test is suitable for its intended use. As such, it is an essential requirement for any package of information submitted to regulatory agencies in support of new product marketing or clinical trial applications. Currently, there is no single source or final guideline on analytical method validation that helps analysts to perform validation in a systematic manner. Therefore, industry depends on the analyst's knowledge and experience to develop simple and efficient methods of analysis. The intention of this paper is to review regulatory requirements and role of the pharmacopeias and to study how analytical method development and validation are typically carried out at present, and to formulate this into a simple step by step approach. Such a template was not only used as the foundation of this research programme, but could also serve as a simple systematic guide for other practitioners and those new to the field. Furthermore, it was recognized that this protocol should satisfy the requirements of the most strategically important regulatory bodies.
- 1 June 2006
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 29 (9) , 1257-1270
Method Development and Validation for the HPLC Assay of Hydrolysed Gelatine
This paper describes the development and validation a of reversed‐phase high performance liquid chromatography (RP‐HPLC) method for the assay of hydrolysed gelatine (Gelita‐Sol P, trade name). Key chromatographic parameters were investigated, including short and long alkyl chains of stationary phases (C4 and C18), column temperatures (30–60°C), and additives of ion‐pairing reagents (trifluoroacetic acid and heptafluorobutyric acid) in the mobile phase. Analytical validation parameters such as specificity and selectivity, linearity, accuracy, precision, limit of detection, limit of quantitation, robustness, and system suitability, were evaluated. The calibration curve for hydrolysed gelatine was linear (r 2=0.997) from 20–200% range of the analytical concentration of 50 mg/mL. The precision of this method calculated as the relative standard deviation (R.S.D.) was 1.22% (n=6). The R.S.D. for the intermediate precision study was 1.77, and recovery of the hydrolysed gelatine ranged between 97.08 and 97.76%. The limits of detection and quantitation were determined to be 5.0 and 10.0 mg/mL, respectively.
- 1 June 2006
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 29 (9) , 1257-1270
Method Development and Validation for the HPLC Assay of Hydrolysed Gelatine
This paper describes the development and validation a of reversed‐phase high performance liquid chromatography (RP‐HPLC) method for the assay of hydrolysed gelatine (Gelita‐Sol P, trade name). Key chromatographic parameters were investigated, including short and long alkyl chains of stationary phases (C4 and C18), column temperatures (30–60°C), and additives of ion‐pairing reagents (trifluoroacetic acid and heptafluorobutyric acid) in the mobile phase. Analytical validation parameters such as specificity and selectivity, linearity, accuracy, precision, limit of detection, limit of quantitation, robustness, and system suitability, were evaluated. The calibration curve for hydrolysed gelatine was linear (r 2=0.997) from 20–200% range of the analytical concentration of 50 mg/mL. The precision of this method calculated as the relative standard deviation (R.S.D.) was 1.22% (n=6). The R.S.D. for the intermediate precision study was 1.77, and recovery of the hydrolysed gelatine ranged between 97.08 and 97.76%. The limits of detection and quantitation were determined to be 5.0 and 10.0 mg/mL, respectively.
- 1 September 2005
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 39 (3-4) , 681-684
Method development and validation for the GC–FID assay of p-cymene in tea tree oil formulation
- 1 September 2005
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 39 (3-4) , 681-684
Method development and validation for the GC–FID assay of p-cymene in tea tree oil formulation